{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:31:14Z","timestamp":1759336274880},"reference-count":94,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of the American Medical Directors Association"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.jamda.2005.12.003","type":"journal-article","created":{"date-parts":[[2006,2,25]],"date-time":"2006-02-25T12:16:16Z","timestamp":1140869776000},"page":"180-192","source":"Crossref","is-referenced-by-count":48,"title":["Difficult Behaviors in Long-term Care Patients With Dementia"],"prefix":"10.1016","volume":"7","author":[{"given":"Gwendolen T.","family":"Buhr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heidi K.","family":"White","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jamda.2005.12.003_bib1","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1093\/geront\/33.6.714","article-title":"Factors determining the decision to institutionalize dementing individuals","volume":"33","author":"Cohen","year":"1993","journal-title":"Gerontologist"},{"key":"10.1016\/j.jamda.2005.12.003_bib2","doi-asserted-by":"crossref","first-page":"M693","DOI":"10.1093\/gerona\/56.11.M693","article-title":"Factors associated with long-term institutionalization of older people with dementia","volume":"56","author":"Hebert","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/j.jamda.2005.12.003_bib3","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1001\/jama.287.16.2090","article-title":"Patient and caregiver characteristics and nursing home placement in patients with dementia","volume":"287","author":"Yaffe","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/j.jamda.2005.12.003_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1017\/S1041610290000266","article-title":"The prevalence and management of dementia and other psychiatric disorders in nursing homes","volume":"2","author":"Rovner","year":"1990","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2005.12.003_bib5","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1176\/ajp.143.11.1446","article-title":"Prevalence of mental illness in a community nursing home","volume":"143","author":"Rovner","year":"1986","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib6","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1532-5415.1986.tb04302.x","article-title":"Agitated behaviors in the elderly. I. A conceptual review","volume":"34","author":"Cohen-Mansfield","year":"1986","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2005.12.003_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/gps.930080603","article-title":"Aggressive behaviour in elderly people with dementia","volume":"8","author":"Patel","year":"1993","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib8","series-title":"Hospice Care for Patients With Advanced Progressive Dementia","first-page":"68","article-title":"Behavioral symptoms of dementia","author":"Volicer","year":"1998"},{"key":"10.1016\/j.jamda.2005.12.003_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3928\/0098-9134-19921101-08","article-title":"Goal-directed care","volume":"18","author":"Ryden","year":"1992","journal-title":"J Gerontol Nurs"},{"key":"10.1016\/j.jamda.2005.12.003_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3928\/0098-9134-19910401-08","article-title":"Nursing care of cognitively impaired, institutionalized elderly","volume":"17","author":"Burgener","year":"1991","journal-title":"J Gerontol Nurs"},{"key":"10.1016\/j.jamda.2005.12.003_bib11","series-title":"Accepting the Challenge [DVD]","author":"Snow","year":"2003"},{"key":"10.1016\/j.jamda.2005.12.003_bib12","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/geront\/42.4.487","article-title":"Teaching and maintaining behavior management skills in the nursing home","volume":"42","author":"Burgio","year":"2002","journal-title":"Gerontologist"},{"key":"10.1016\/j.jamda.2005.12.003_bib13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1093\/geront\/35.5.672","article-title":"Bathing persons with dementia","volume":"35","author":"Sloane","year":"1995","journal-title":"Gerontologist"},{"key":"10.1016\/j.jamda.2005.12.003_bib14","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1111\/j.1532-5415.2004.52501.x","article-title":"Effect of person-centered showering and the towel bath on bathing-associated aggression, agitation, and discomfort in nursing home residents with dementia","volume":"52","author":"Sloane","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2005.12.003_bib15","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1532-5415.1996.tb05631.x","article-title":"A randomized trial of dementia care in nursing homes","volume":"44","author":"Rovner","year":"1996","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2005.12.003_bib16","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3928\/0098-9134-20020301-09","article-title":"Snoezelen","volume":"28","author":"Chitsey","year":"2002","journal-title":"J Gerontol Nurs"},{"key":"10.1016\/j.jamda.2005.12.003_bib17","series-title":"Behaviors in Dementia","first-page":"155","article-title":"Nonpharmacological approaches to the management of the behavioral consequences of advanced dementia","author":"Volicer","year":"1998"},{"key":"10.1016\/j.jamda.2005.12.003_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1532-5415.2005.53006.x","article-title":"Behavioral and mood effects of snoezelen integrated into 24-hour dementia care","volume":"53","author":"van Weert","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2005.12.003_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S0197-4572(05)80418-5","article-title":"Exercise as an intervention for behavior problems","volume":"13","author":"Beck","year":"1992","journal-title":"Geriatr Nurs"},{"key":"10.1016\/j.jamda.2005.12.003_bib20","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1532-5415.1999.tb07237.x","article-title":"Evaluation of simulated presence","volume":"47","author":"Camberg","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2005.12.003_bib21","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/00006199-200209000-00008","article-title":"Calming music and hand massage with agitated elderly","volume":"51","author":"Remington","year":"2002","journal-title":"Nurs Res"},{"key":"10.1016\/j.jamda.2005.12.003_bib22","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/0883-9417(94)90048-5","article-title":"Effects of relaxing music on agitation during meals among nursing home residents with severe cognitive impairment","volume":"8","author":"Goddaer","year":"1994","journal-title":"Arch Psychiatr Nurs"},{"key":"10.1016\/j.jamda.2005.12.003_bib23","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1017\/S1041610200006190","article-title":"Effects of individualized versus classical \u201crelaxation\u201d music on the frequency of agitation in elderly persons with Alzheimer\u2019s disease and related disorders","volume":"12","author":"Gerdner","year":"2000","journal-title":"Int Psychogeriatr"},{"key":"10.1016\/j.jamda.2005.12.003_bib24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1046\/j.1365-2702.2001.00545.x","article-title":"Integration of lucid individuals and agitated individuals with dementia in different care units","volume":"10","author":"Ragneskog","year":"2001","journal-title":"J Clin Nurs"},{"key":"10.1016\/j.jamda.2005.12.003_bib25","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/j.1532-5415.2004.52304.x","article-title":"Special care facility compared with traditional environments for dementia care","volume":"52","author":"Reimer","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2005.12.003_bib26","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/geront\/38.2.199","article-title":"The effects of an enhanced environment on nursing home residents who pace","volume":"38","author":"Cohen-Mansfield","year":"1998","journal-title":"Gerontologist"},{"key":"10.1016\/j.jamda.2005.12.003_bib27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1525-8610(04)70347-3","article-title":"Sexuality in the nursing home, part 2","volume":"4","author":"Kamel","year":"2003","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2005.12.003_bib28","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1532-5415.1999.tb04583.x","article-title":"Pharmacologic treatment of hypersexuality and paraphilias in nursing home residents","volume":"47","author":"Levitsky","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2005.12.003_bib29","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1212\/WNL.54.10.2024","article-title":"Hypersexuality in patients with dementia","volume":"54","author":"Wiseman","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2005.12.003_bib30","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1046\/j.1532-5415.2003.514204.x","article-title":"Role of cholinesterase inhibitor in the management of sexual aggression in an elderly demented woman","volume":"51","author":"Alagiakrishnan","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2005.12.003_bib31","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1532-5415.1999.tb03833.x","article-title":"A randomized trial of a combined physical activity and environmental intervention in nursing home residents","volume":"47","author":"Alessi","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2005.12.003_bib32","series-title":"Management of Challenging Behaviors in Dementia","author":"Mahoney","year":"2000"},{"key":"10.1016\/j.jamda.2005.12.003_bib33","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/S1525-8610(04)70061-4","article-title":"A 6-month observational study of the relationship between weight loss and behavioral symptoms in institutionalized Alzheimer\u2019s disease subjects","volume":"5","author":"White","year":"2004","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/j.jamda.2005.12.003_bib34","series-title":"Alzheimer\u2019s disease","first-page":"9","article-title":"Neurotransmitter deficits in Alzheimer\u2019s disease","author":"Cowburn","year":"1989"},{"key":"10.1016\/j.jamda.2005.12.003_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1176\/appi.neuropsych.13.1.5","article-title":"Role of serotonin in the behavioral and psychological symptoms of dementia","volume":"13","author":"Lanctot","year":"2001","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jamda.2005.12.003_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1136\/bmj.38125.465579.55","article-title":"Atypical antipsychotic drugs in the treatment of behavioural and psychological symptoms of dementia","volume":"329","author":"Lee","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.jamda.2005.12.003_bib37","doi-asserted-by":"crossref","unstructured":"Lonergan E, Luxenberg J, Colford J. Haloperidol for agitation in dementia. Cochrane Database Syst Rev2002:CD002852.","DOI":"10.1002\/14651858.CD002852"},{"key":"10.1016\/j.jamda.2005.12.003_bib38","unstructured":"Alexopoulos GS, Jeste DV, Chung H, Carpenter D, Ross R, Docherty JP. The expert consensus guideline series: Treatment of dementia and its behavioral disturbances. Postgraduate Medicine Special Report 2005;January:1\u2013107."},{"issue":"Suppl","key":"10.1016\/j.jamda.2005.12.003_bib39","first-page":"9","article-title":"Behavioral symptoms in Alzheimer\u2019s disease","volume":"48","author":"Reisberg","year":"1987","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib40","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4088\/JCP.v60n0207","article-title":"Comparison of risperidone and placebo for psychosis and behavioral disturbances associated with dementia","volume":"60","author":"Katz","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib41","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4088\/JCP.v64n0205","article-title":"A randomized placebo-controlled trial of risperidone for the treatment of aggression, agitation, and psychosis of dementia","volume":"64","author":"Brodaty","year":"2003","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib42","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1111\/j.1532-5415.2004.52406.x","article-title":"The effect of risperidone on nursing burden associated with caring for patients with dementia","volume":"52","author":"Frank","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2005.12.003_bib43","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1212\/WNL.53.5.946","article-title":"A randomized trial of risperidone, placebo, and haloperidol for behavioral symptoms of dementia","volume":"53","author":"De Deyn","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2005.12.003_bib44","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1001\/archpsyc.57.10.968","article-title":"Olanzapine treatment of psychotic and behavioral symptoms in patients with Alzheimer disease in nursing care facilities","volume":"57","author":"Street","year":"2000","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib45","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The Neuropsychiatric Inventory","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2005.12.003_bib46","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1002\/gps.1032","article-title":"Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer\u2019s disease","volume":"19","author":"De Deyn","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib47","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1136\/bmj.38369.459988.8F","article-title":"Quetiapine and rivastigmine and cognitive decline in Alzheimer\u2019s disease","volume":"330","author":"Ballard","year":"2005","journal-title":"BMJ"},{"issue":"12 Suppl","key":"10.1016\/j.jamda.2005.12.003_bib48","doi-asserted-by":"crossref","first-page":"S272","DOI":"10.1111\/j.1532-5415.2004.52604.x","article-title":"Optimizing atypical antipsychotic treatment strategies in the elderly","volume":"52","author":"Katz","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2005.12.003_bib49","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","volume":"27","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jamda.2005.12.003_bib50","unstructured":"Risperdal (risperidone) and cerebrovascular adverse events in placebo-controlled dementia trials. Dear Healthcare Professional Letter; October 11, 2002. Available at: www.hc-sc.gc.ca\/hpfb-dgpsa\/tpd-dpt\/risperdal1_e.pdf. Accessed January 5, 2005."},{"key":"10.1016\/j.jamda.2005.12.003_bib51","unstructured":"Dear Healthcare Professional Letter; April 16, 2003. Available at: www.fda.gov\/medwatch\/SAFETY\/2003\/risperdal.html. Accessed January 5, 2005."},{"key":"10.1016\/j.jamda.2005.12.003_bib52","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1176\/appi.ajp.161.6.1113","article-title":"Atypical antipsychotics and risk of cerebrovascular accidents","volume":"161","author":"Herrmann","year":"2004","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib53","unstructured":"EMEA public statement on the safety of olanzapine; March 9, 2004. Available at: www.emea.eu.int\/pdfs\/human\/press\/pus\/085604en.pdf Accessed January 5, 2005."},{"key":"10.1016\/j.jamda.2005.12.003_bib54","unstructured":"Atypical antipsychotic drugs and stroke: Message from Professor Gordon Duff, Chairman, Committee on Safety of Medicines; March 9, 2004. Available at: http:\/\/www.mhra.gov.uk\/home\/groups\/pl-p\/documents\/drugsafetymessage\/con019488.pdf. Accessed January 5, 2005."},{"key":"10.1016\/j.jamda.2005.12.003_bib55","unstructured":"FDA public health advisory: Deaths with antipsychotics in elderly patients with behavioral disturbances; April 11, 2005. Available at: www.fda.gov\/cder\/drug\/advisory\/antipsychotics.htm. Accessed April 13, 2005."},{"key":"10.1016\/j.jamda.2005.12.003_bib56","unstructured":"CATIE: Clinical Antipsychotic Trials of Intervention Effectiveness. A research program studying treatment effectiveness and outcomes in schizophrenia and Alzheimer\u2019s disease. Available at: http:\/\/www.catie.unc.edu. Accessed January 12, 2005."},{"key":"10.1016\/j.jamda.2005.12.003_bib57","first-page":"439","article-title":"GABAergic function in Alzheimer\u2019s disease","volume":"49","author":"Lanctot","year":"2004","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib58","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0165-1781(01)00220-7","article-title":"Plasma GABA levels correlate with aggressiveness in relatives of patients with unipolar depressive disorder","volume":"101","author":"Bjork","year":"2001","journal-title":"Psychiatry Res"},{"key":"10.1016\/j.jamda.2005.12.003_bib59","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1176\/ajp.155.1.54","article-title":"Efficacy and tolerability of carbamazepine for agitation and aggression in dementia","volume":"155","author":"Tariot","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib60","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1097\/00019442-200102000-00009","article-title":"Placebo-controlled study of divalproex sodium for agitation in dementia","volume":"9","author":"Porsteinsson","year":"2001","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib61","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0011-393X(01)80042-4","article-title":"Safety and tolerability of divalproex sodium for the treatment of signs and symptoms of mania in elderly patients with dementia","volume":"62","author":"Tariot","year":"2001","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/j.jamda.2005.12.003_bib62","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/gps.653","article-title":"Sodium valproate in the treatment of aggressive behavior in patients with dementia\u2014a randomized placebo controlled clinical trial","volume":"17","author":"Sival","year":"2002","journal-title":"Int J Geriatr Psychiatry"},{"issue":"2 Suppl 1","key":"10.1016\/j.jamda.2005.12.003_bib63","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1097\/00019442-199821001-00009","article-title":"The cholinergic hypothesis of neuropsychiatric symptoms in Alzheimer\u2019s disease","volume":"6","author":"Cummings","year":"1998","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib64","doi-asserted-by":"crossref","unstructured":"Birks JS, Harvey R. Donepezil for dementia due to Alzheimer\u2019s disease. Cochrane Database Syst Rev2003:CD001190.","DOI":"10.1002\/14651858.CD001190"},{"key":"10.1016\/j.jamda.2005.12.003_bib65","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1212\/WNL.57.4.613","article-title":"A 24-week, randomized, double-blind study of donepezil in moderate to severe Alzheimer\u2019s disease","volume":"57","author":"Feldman","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2005.12.003_bib66","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1111\/j.1532-5415.2001.49266.x","article-title":"A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer\u2019s disease in the nursing home setting","volume":"49","author":"Tariot","year":"2001","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/j.jamda.2005.12.003_bib67","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1212\/01.WNL.0000129990.32253.7B","article-title":"The efficacy of donepezil in the treatment of neuropsychiatric symptoms in Alzheimer disease","volume":"63","author":"Holmes","year":"2004","journal-title":"Neurology"},{"issue":"9427","key":"10.1016\/j.jamda.2005.12.003_bib68","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(04)16499-4","article-title":"Long-term donepezil treatment in 565 patients with Alzheimer\u2019s disease (AD2000)","volume":"363","author":"Courtney","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2005.12.003_bib69","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1136\/jnnp.71.5.589","article-title":"Effects of a flexible galantamine dose in Alzheimer\u2019s disease","volume":"71","author":"Rockwood","year":"2001","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib70","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1212\/WNL.54.12.2269","article-title":"A 5-month, randomized, placebo-controlled trial of galantamine in AD","volume":"54","author":"Tariot","year":"2000","journal-title":"Neurology"},{"issue":"9314","key":"10.1016\/j.jamda.2005.12.003_bib71","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/S0140-6736(02)08267-3","article-title":"Efficacy of galantamine in probable vascular dementia and Alzheimer\u2019s disease combined with cerebrovascular disease","volume":"359","author":"Erkinjuntti","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.jamda.2005.12.003_bib72","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.neuint.2004.03.007","article-title":"Glutamate-mediated excitotoxicity and neurodegeneration in Alzheimer\u2019s disease","volume":"45","author":"Hynd","year":"2004","journal-title":"Neurochem Int"},{"issue":"Suppl 1","key":"10.1016\/j.jamda.2005.12.003_bib73","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1002\/gps.933","article-title":"Glutamate and the glutamate receptor system","volume":"18","author":"Bleich","year":"2003","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib74","doi-asserted-by":"crossref","unstructured":"AreosaSA,SherriffF,McShaneR. Memantine for dementia. Cochrane Database Syst Rev2005:CD003154.","DOI":"10.1002\/14651858.CD003154.pub3"},{"issue":"45 Suppl 1","key":"10.1016\/j.jamda.2005.12.003_bib75","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1159\/000052760","article-title":"Neuropsychiatric symptoms and cholinergic therapy for Alzheimer\u2019s disease","author":"Levy","year":"1999","journal-title":"Gerontology"},{"key":"10.1016\/j.jamda.2005.12.003_bib76","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1176\/ajp.151.7.1006","article-title":"Prevalence and incidence of major depression in Alzheimer\u2019s disease","volume":"151","author":"Weiner","year":"1994","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib77","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1176\/ajp.146.3.350","article-title":"Depression and Alzheimer\u2019s disease","volume":"146","author":"Rovner","year":"1989","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib78","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/1099-1166(200102)16:2<139::AID-GPS284>3.0.CO;2-5","article-title":"Relationship between aggressive behaviors and depression among nursing home residents with dementia","volume":"16","author":"Menon","year":"2001","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib79","first-page":"646","article-title":"Central serotonergic activity is related to the aggressive behaviors of Alzheimer\u2019s disease","volume":"27","author":"Lanctot","year":"2002","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jamda.2005.12.003_bib80","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1192\/bjp.157.6.894","article-title":"The clinical efficacy of citalopram in treatment of emotional disturbances in dementia disorders. A Nordic multicentre study","volume":"157","author":"Nyth","year":"1990","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib81","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1176\/appi.ajp.159.3.460","article-title":"Comparison of citalopram, perphenazine, and placebo for the acute treatment of psychosis and behavioral disturbances in hospitalized, demented patients","volume":"159","author":"Pollock","year":"2002","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib82","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/00005053-200102000-00011","article-title":"Fluvoxamine for psychosis in Alzheimer\u2019s disease","volume":"189","author":"Levkovitz","year":"2001","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/j.jamda.2005.12.003_bib83","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/archpsyc.60.7.737","article-title":"Treating depression in Alzheimer disease: Efficacy and safety of sertraline therapy, and the benefits of depression reduction: The DIADS","volume":"60","author":"Lyketsos","year":"2003","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib84","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1176\/jnp.8.3.270","article-title":"A double-blind placebo-controlled study of clomipramine in depressed patients with Alzheimer\u2019s disease","volume":"8","author":"Petracca","year":"1996","journal-title":"J Neuropsychiatry Clin Neurosci"},{"key":"10.1016\/j.jamda.2005.12.003_bib85","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1176\/ajp.146.1.45","article-title":"Double-blind trial of imipramine in Alzheimer\u2019s disease patients with and without depression","volume":"146","author":"Reifler","year":"1989","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib86","doi-asserted-by":"crossref","first-page":"P372","DOI":"10.1093\/geronj\/46.6.P372","article-title":"Imipramine in the treatment of depressed Alzheimer\u2019s patients","volume":"46","author":"Teri","year":"1991","journal-title":"J Gerontol"},{"key":"10.1016\/j.jamda.2005.12.003_bib87","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1212\/WNL.55.9.1271","article-title":"Treatment of agitation in AD","volume":"55","author":"Teri","year":"2000","journal-title":"Neurology"},{"key":"10.1016\/j.jamda.2005.12.003_bib88","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/00019442-200002000-00009","article-title":"A controlled clinical trial of sertraline in the treatment of depression in nursing home patients with late-stage Alzheimer\u2019s disease","volume":"8","author":"Magai","year":"2000","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib89","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/gps.998","article-title":"A randomized, placebo-controlled study of the efficacy and safety of sertraline in the treatment of the behavioral manifestations of Alzheimer\u2019s disease in outpatients treated with donepezil","volume":"19","author":"Finkel","year":"2004","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib90","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/geront\/31.3.413","article-title":"Cognitive-behavioral interventions for treatment of depression in Alzheimer\u2019s patients","volume":"31","author":"Teri","year":"1991","journal-title":"Gerontologist"},{"key":"10.1016\/j.jamda.2005.12.003_bib91","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1080\/136078603100015947","article-title":"Group psychotherapy and people with dementia","volume":"7","author":"Cheston","year":"2003","journal-title":"Aging Ment Health"},{"key":"10.1016\/j.jamda.2005.12.003_bib92","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1176\/ajp.155.11.1626a","article-title":"Violent behavior associated with donepezil","volume":"155","author":"Bouman","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.jamda.2005.12.003_bib93","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s100720100012","article-title":"Rivastagmine-induced agitation following transient recollection of autobiographical memory","volume":"22","author":"Caffarra","year":"2001","journal-title":"Neurol Sci"},{"key":"10.1016\/j.jamda.2005.12.003_bib94","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1046\/j.1440-1614.2001.0950f.x","article-title":"Adverse reactions to rivastigmine in three cases of dementia","volume":"35","author":"Smith","year":"2001","journal-title":"Aust N Z J Psychiatry"}],"container-title":["Journal of the American Medical Directors Association"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861005006778?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525861005006778?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T03:03:11Z","timestamp":1555470191000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525861005006778"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":94,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S1525861005006778"],"URL":"https:\/\/doi.org\/10.1016\/j.jamda.2005.12.003","relation":{},"ISSN":["1525-8610"],"issn-type":[{"value":"1525-8610","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]}}}